Avance Clinical the leading award-winning Australian and North American CRO that offers ClinicReady and GlobalReady for early-phase biotech companies to speed up the path to regulatory approval, says early-phase oncology studies are increasingly more complex and demand more patients.
EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside ...
The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client XWPharma on receiving positive results from its Phase 1 clinical trial of XW10172.
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial.
Avance Clinical today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO).
Avance Clinical's Oncology Center of Excellence meets sponsors at ESMO Congress 2026 (23–27 Oct, Madrid) to talk about trial strategy. Book a meeting.
Avance Clinical exhibits at ASN Kidney Week 2026, Booth 234. Discuss renal & cardiometabolic trial design and global patient access. Book a meeting
What's fueling the surge of Chinese biotechs onto the world stage, and what decisions do they face on the path to their first global clinical trial?
Avance Clinical's CNS Center of Excellence joins CNS Therapeutics Xchange San Francisco 2026 to tackle screen failure and attrition in CNS trials.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com